DK244577A - Fremgangsmade til fremstilling af hydantoinderivater - Google Patents

Fremgangsmade til fremstilling af hydantoinderivater

Info

Publication number
DK244577A
DK244577A DK244577A DK244577A DK244577A DK 244577 A DK244577 A DK 244577A DK 244577 A DK244577 A DK 244577A DK 244577 A DK244577 A DK 244577A DK 244577 A DK244577 A DK 244577A
Authority
DK
Denmark
Prior art keywords
interventives
hydanto
procedure
preparation
hydanto interventives
Prior art date
Application number
DK244577A
Other languages
Danish (da)
English (en)
Inventor
A G Caldwell
N Whittaker
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK244577A publication Critical patent/DK244577A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK244577A 1976-06-03 1977-06-02 Fremgangsmade til fremstilling af hydantoinderivater DK244577A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2287776 1976-06-03
GB5034076 1976-12-02
GB1214577 1977-03-23

Publications (1)

Publication Number Publication Date
DK244577A true DK244577A (da) 1977-12-04

Family

ID=27256793

Family Applications (1)

Application Number Title Priority Date Filing Date
DK244577A DK244577A (da) 1976-06-03 1977-06-02 Fremgangsmade til fremstilling af hydantoinderivater

Country Status (12)

Country Link
JP (1) JPS52151168A (de)
CA (1) CA1176261A (de)
CH (3) CH645631A5 (de)
DE (1) DE2724948A1 (de)
DK (1) DK244577A (de)
ES (5) ES459412A1 (de)
FI (1) FI71930C (de)
FR (1) FR2362839A1 (de)
HU (1) HU183046B (de)
NL (1) NL7706064A (de)
NZ (1) NZ184281A (de)
SE (2) SE446336B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602188A (en) * 1977-12-01 1981-11-11 Wellcome Found Hydantoin derivatives
IE48747B1 (en) * 1977-09-05 1985-05-15 Wellcome Found Hydantoin derivatives
DK543178A (da) * 1977-12-01 1979-06-02 Wellcome Found Thiodydantoinderivater
DE2963795D1 (en) * 1978-01-23 1982-11-11 Beecham Group Plc Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them
EP0004723A1 (de) * 1978-03-30 1979-10-17 Beecham Group Plc Deoxyhydantoine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
GB1599740A (en) * 1978-05-31 1981-10-07 Wellcome Found Hydantoin derivatives
EP0006352A1 (de) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoine und Thiohydantoine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2965099D1 (en) * 1978-06-15 1983-05-05 Beecham Group Plc Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
GB2050371A (en) * 1979-05-09 1981-01-07 Wellcome Found Optically active hydantoin derivatives and pharmaceutical formulations containing them
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JP3022878U (ja) * 1995-08-18 1996-04-02 有限会社春江加工 ミニディスク用ケース
EP1453811A2 (de) 2001-11-30 2004-09-08 Eli Lilly And Company Agonisten des peroxisome proliferator activated receptor
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
WO2004108215A1 (en) * 2003-06-06 2004-12-16 Allergan, Inc. Piperidinyl prostaglandin e analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524818A (en) * 1974-11-29 1978-09-13 Beecham Group Ltd 12-azaprostaglandins

Also Published As

Publication number Publication date
NL7706064A (nl) 1977-12-06
CA1176261A (en) 1984-10-16
FR2362839B1 (de) 1980-02-01
SE446336B (sv) 1986-09-01
ES482010A1 (es) 1980-08-16
FI71930B (fi) 1986-11-28
FI71930C (fi) 1987-03-09
ES478156A1 (es) 1979-11-01
FR2362839A1 (fr) 1978-03-24
JPS6222986B2 (de) 1987-05-20
JPS52151168A (en) 1977-12-15
NZ184281A (en) 1980-04-28
ES489883A0 (es) 1981-02-16
CH645631A5 (en) 1984-10-15
SE8203161L (sv) 1982-05-19
HU183046B (en) 1984-04-28
CH647511A5 (en) 1985-01-31
ES8103057A1 (es) 1981-02-16
FI771763A (fi) 1977-12-04
ES459412A1 (es) 1978-11-01
CH646426A5 (en) 1984-11-30
ES470428A1 (es) 1979-09-01
SE7706428L (sv) 1977-12-04
DE2724948A1 (de) 1977-12-15

Similar Documents

Publication Publication Date Title
DK30277A (da) Fremgangsmade til fremstilling af substituerede phenylamidiner
DK142372C (da) Fremgangsmaade til fremstilling af androstan-17-on-derivater
DK377A (da) Fremgangsmade til fremstilling af n-phosphonomethyl-glycin
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK276177A (da) Fremgangsmade til fremstilling af gammapyron-forbindelser
DK577977A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK587077A (da) Fremgangsmaade til fremstilling af estere
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK118177A (da) Fremgangsmade til fremstilling af isobutyramidderivater
DK88777A (da) Fremgangsmade til fremstilling af substituerede azapuriner
DK233477A (da) Fremgangsmade til fremstilling af antiotiske midler
DK271377A (da) Fremgangsmade til fremstilling af substituerede arylacetamidocephalosporiner
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK73277A (da) Fremgangsmaade til fremstilling af sulfonylbenzimidazoler
DK575277A (da) Fremgangsmaade til fremstilling af basisk substituerede 0-propyloximer
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK123177A (da) Fremgangsmade til fremstilling af 7-alkoxy-3-chlormethyl-3-cephem-forbindelser
DK564977A (da) Fremgangsmaade til fremstilling af antirhinovirusmidler
DK553077A (da) Fremgangsmaade til fremstilling af n-propylnorapomorphindiestere
DK301377A (da) Fremgangsmade til fremstilling af cishexahydrodibenzopyranoner
DK582177A (da) Fremgangsmaade til fremstilling af halogenacylamider
DK338677A (da) Frefmgangsmade til fremstilling af 3-alkoxycyproheptadiner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment